Log in to save to my catalogue

Pembrolizumab monotherapy in advanced triple-negative breast cancer

Pembrolizumab monotherapy in advanced triple-negative breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2537632619

Pembrolizumab monotherapy in advanced triple-negative breast cancer

About this item

Full title

Pembrolizumab monotherapy in advanced triple-negative breast cancer

Publisher

London: Elsevier Ltd

Journal title

The lancet oncology, 2021-06, Vol.22 (6), p.e224-e224

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Alternative Titles

Full title

Pembrolizumab monotherapy in advanced triple-negative breast cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2537632619

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2537632619

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(21)00249-7

How to access this item